203 related articles for article (PubMed ID: 24999657)
21. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
Dasgupta A; Das S; Izumi R; Venkatesan A; Barat B
FEMS Microbiol Lett; 2004 May; 234(2):189-99. PubMed ID: 15135522
[TBL] [Abstract][Full Text] [Related]
22. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation.
Ali N; Pruijn GJ; Kenan DJ; Keene JD; Siddiqui A
J Biol Chem; 2000 Sep; 275(36):27531-40. PubMed ID: 10856291
[TBL] [Abstract][Full Text] [Related]
23. Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection.
Kanda T; Sasaki R; Masuzaki R; Matsumoto N; Ogawa M; Moriyama M
Viruses; 2020 May; 12(5):. PubMed ID: 32408660
[TBL] [Abstract][Full Text] [Related]
24. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
25. Loxapine inhibits replication of hepatitis A virus in vitro and in vivo by targeting viral protein 2C.
Matsuda M; Hirai-Yuki A; Kotani O; Kataoka M; Zheng X; Yamane D; Yokoyama M; Ishii K; Muramatsu M; Suzuki R
PLoS Pathog; 2024 Mar; 20(3):e1012091. PubMed ID: 38478584
[TBL] [Abstract][Full Text] [Related]
26. Masitinib Inhibits Hepatitis A Virus Replication.
Sasaki-Tanaka R; Shibata T; Moriyama M; Kogure H; Hirai-Yuki A; Okamoto H; Kanda T
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298659
[TBL] [Abstract][Full Text] [Related]
27. La protein is required for efficient translation driven by encephalomyocarditis virus internal ribosomal entry site.
Kim YK; Jang SK
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3159-3166. PubMed ID: 10567647
[TBL] [Abstract][Full Text] [Related]
28. A genome-wide CRISPR screen identifies UFMylation and TRAMP-like complexes as host factors required for hepatitis A virus infection.
Kulsuptrakul J; Wang R; Meyers NL; Ott M; Puschnik AS
Cell Rep; 2021 Mar; 34(11):108859. PubMed ID: 33730579
[TBL] [Abstract][Full Text] [Related]
29. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
30. La autoantigen enhances translation of BiP mRNA.
Kim YK; Back SH; Rho J; Lee SH; Jang SK
Nucleic Acids Res; 2001 Dec; 29(24):5009-16. PubMed ID: 11812831
[TBL] [Abstract][Full Text] [Related]
31. Translation directed by hepatitis A virus IRES in the absence of active eIF4F complex and eIF2.
Redondo N; Sanz MA; Steinberger J; Skern T; Kusov Y; Carrasco L
PLoS One; 2012; 7(12):e52065. PubMed ID: 23272212
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis A Virus Genome Organization and Replication Strategy.
McKnight KL; Lemon SM
Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29610147
[TBL] [Abstract][Full Text] [Related]
33. A cell-permeable peptide inhibits hepatitis C virus replication by sequestering IRES transacting factors.
Fontanes V; Raychaudhuri S; Dasgupta A
Virology; 2009 Nov; 394(1):82-90. PubMed ID: 19740508
[TBL] [Abstract][Full Text] [Related]
34. Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs.
Broeckel R; Sarkar S; May NA; Totonchy J; Kreklywich CN; Smith P; Graves L; DeFilippis VR; Heise MT; Morrison TE; Moorman N; Streblow DN
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917980
[TBL] [Abstract][Full Text] [Related]
35. Low efficiency of the 5' nontranslated region of hepatitis A virus RNA in directing cap-independent translation in permissive monkey kidney cells.
Whetter LE; Day SP; Elroy-Stein O; Brown EA; Lemon SM
J Virol; 1994 Aug; 68(8):5253-63. PubMed ID: 8035522
[TBL] [Abstract][Full Text] [Related]
36. TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions.
Das A; Hirai-Yuki A; González-López O; Rhein B; Moller-Tank S; Brouillette R; Hensley L; Misumi I; Lovell W; Cullen JM; Whitmire JK; Maury W; Lemon SM
mBio; 2017 Sep; 8(5):. PubMed ID: 28874468
[TBL] [Abstract][Full Text] [Related]
37. Silencing of hepatitis A virus infection by small interfering RNAs.
Kusov Y; Kanda T; Palmenberg A; Sgro JY; Gauss-Müller V
J Virol; 2006 Jun; 80(11):5599-610. PubMed ID: 16699041
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA.
Brack K; Berk I; Magulski T; Lederer J; Dotzauer A; Vallbracht A
J Virol; 2002 Dec; 76(23):11920-30. PubMed ID: 12414934
[TBL] [Abstract][Full Text] [Related]
39. The ZCCHC14/TENT4 complex is required for hepatitis A virus RNA synthesis.
Li Y; Misumi I; Shiota T; Sun L; Lenarcic EM; Kim H; Shirasaki T; Hertel-Wulff A; Tibbs T; Mitchell JE; McKnight KL; Cameron CE; Moorman NJ; McGivern DR; Cullen JM; Whitmire JK; Lemon SM
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2204511119. PubMed ID: 35867748
[TBL] [Abstract][Full Text] [Related]
40. Amantadine and Rimantadine Inhibit Hepatitis A Virus Replication through the Induction of Autophagy.
Sasaki-Tanaka R; Shibata T; Moriyama M; Okamoto H; Kogure H; Kanda T
J Virol; 2022 Sep; 96(18):e0064622. PubMed ID: 36040176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
